Código QR (código de barras bidimensional)

The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis

BackgroundCombination of multiple therapies is a common approach to treating patients with unresectable hepatocellular carcinoma (uHCC). The impact of immune checkpoint inhibitors (ICIs) on prognosis in uHCC patients treated with transarterial chemoembolization (TACE) and lenvatinib remains unclear....

ver descrição completa

Na minha lista:
Principais autores: Wei Zhang, Zirong Liu, Hongjin Liu, Zhangkan Huang, Xiaozhun Huang, Lin Xu, Xu Che, Zhengyin Zhan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2025-05-01
coleção:Frontiers in Immunology
Assuntos:
hepatocellular carcinoma
transarterial chemoembolization
lenvatinib
immune checkpoint inhibitor
PD-1 inhibitor
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1573505/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados